Clinical Trial Update: North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for North American study addressing epistaxis in hereditary hemorrhagic telangiectasia (HHT) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epistaxis
• Hereditary Hemorrhagic Telangiectasia

Snippet

Sponsor: James Gossage | Conditions: Telangiectasia, Hereditary Hemorrhagic, Epistaxis | Phase 2 | Status: COMPLETED | Results posted: 2018-10-19